These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35178567)

  • 1. Tigecycline population pharmacokinetics in critically ill patients with decompensated cirrhosis and severe infections.
    Bastida C; Hernández-Tejero M; Cariqueo M; Aziz F; Fortuna V; Sanz M; Brunet M; Fernández J; Soy D
    J Antimicrob Chemother; 2022 Apr; 77(5):1365-1371. PubMed ID: 35178567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meropenem population pharmacokinetics in patients with decompensated cirrhosis and severe infections.
    Bastida C; Hernández-Tejero M; Aziz F; Espinosa C; Sanz M; Brunet M; López E; Fernández J; Soy D
    J Antimicrob Chemother; 2020 Dec; 75(12):3619-3624. PubMed ID: 32887993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monte Carlo simulation evaluation of tigecycline dosing for bacteria with raised minimum inhibitory concentrations in non-critically ill adults.
    Kispal B; Walker SAN
    Eur J Clin Pharmacol; 2021 Feb; 77(2):197-205. PubMed ID: 32975650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population Pharmacokinetics of Tigecycline in Critically Ill Patients with Severe Infections.
    Xie J; Roberts JA; Alobaid AS; Roger C; Wang Y; Yang Q; Sun J; Dong H; Wang X; Xing J; Lipman J; Dong Y
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a dosing algorithm for meropenem in critically ill patients based on a population pharmacokinetic/pharmacodynamic analysis.
    Ehmann L; Zoller M; Minichmayr IK; Scharf C; Huisinga W; Zander J; Kloft C
    Int J Antimicrob Agents; 2019 Sep; 54(3):309-317. PubMed ID: 31229669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of tigecycline in critically ill patients.
    Luo X; Wang S; Li D; Wen J; Sun N; Fan G
    Front Pharmacol; 2023; 14():1083464. PubMed ID: 36992827
    [No Abstract]   [Full Text] [Related]  

  • 7. Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study.
    Broeker A; Wicha SG; Dorn C; Kratzer A; Schleibinger M; Kees F; Heininger A; Kees MG; Häberle H
    Crit Care; 2018 Dec; 22(1):341. PubMed ID: 30558639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population Pharmacokinetics of High-Dose Tigecycline in Patients with Sepsis or Septic Shock.
    Borsuk-De Moor A; Rypulak E; Potręć B; Piwowarczyk P; Borys M; Sysiak J; Onichimowski D; Raszewski G; Czuczwar M; Wiczling P
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Pharmacokinetic Study of the Suitability of Standard Dosing Regimens of Amikacin in Critically Ill Patients with Open-Abdomen and Negative-Pressure Wound Therapy.
    Carrié C; Delzor F; Roure S; Dubuisson V; Petit L; Molimard M; Breilh D; Biais M
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of intravenous sufentanil in critically ill patients supported with extracorporeal membrane oxygenation therapy.
    Hahn J; Yang S; Min KL; Kim D; Jin BH; Park C; Park MS; Wi J; Chang MJ
    Crit Care; 2019 Jul; 23(1):248. PubMed ID: 31288863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population Pharmacokinetics Analysis and Dosing Simulations Of Meropenem in Critically Ill Patients with Pulmonary Infection.
    Lan J; Wu Z; Wang X; Wang Y; Yao F; Zhao BX; Wang Y; Chen J; Chen C
    J Pharm Sci; 2022 Jun; 111(6):1833-1842. PubMed ID: 35090867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-Based Pharmacokinetics and Dose Optimization of Imipenem in Vietnamese Critically-Ill Patients.
    Dinh TD; Nguyen HN; Le BH; Nguyen TTT; Nguyen HTL
    Infect Drug Resist; 2022; 15():4575-4583. PubMed ID: 36003989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NONMEM population pharmacokinetics and Monte Carlo dosing simulations of imipenem in critically ill patients with life-threatening severe infections during support with or without extracorporeal membrane oxygenation in an intensive care unit.
    Jaruratanasirikul S; Boonpeng A; Nawakitrangsan M; Samaeng M
    Pharmacotherapy; 2021 Jul; 41(7):572-597. PubMed ID: 34080708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics and individualized dosing of tigecycline for critically ill patients: a prospective study with intensive sampling.
    Su W; Song S; Liu J; Yu H; Feng B; Wu Y; Guo F; Yu Z
    Front Pharmacol; 2024; 15():1342947. PubMed ID: 38348395
    [No Abstract]   [Full Text] [Related]  

  • 15. Population pharmacokinetic and optimization of polymyxin B dosing in adult patients with various renal functions.
    Yu XB; Jiao Z; Zhang CH; Dai Y; Zhou ZY; Han L; Wen X; Sheng CC; Lin GY; Pan JY
    Br J Clin Pharmacol; 2021 Apr; 87(4):1869-1877. PubMed ID: 33002196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Obesity on the Population Pharmacokinetics of Meropenem in Critically Ill Patients.
    Alobaid AS; Wallis SC; Jarrett P; Starr T; Stuart J; Lassig-Smith M; Ordóñez Mejia JL; Roberts MS; Lipman J; Roberts JA
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4577-84. PubMed ID: 27185798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The population pharmacokinetics and dose optimization of polymyxin B in critically ill patients with or without extracorporeal membrane oxygenation.
    Ye Q; Wang Q; Chen W; Zhang R; Chen Z; Li P; Zhang X; Zhan Q; Wang C
    J Clin Pharm Ther; 2022 Oct; 47(10):1608-1618. PubMed ID: 35716048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic/pharmacodynamic analysis of high-dose tigecycline, by Monte Carlo simulation, in plasma and sputum of patients with hospital-acquired pneumonia.
    Qin X; Kong L; Wu C; Zhang X; Xie M; Wu X
    J Clin Pharm Ther; 2022 Dec; 47(12):2312-2319. PubMed ID: 36479719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population Pharmacokinetics and Pharmacodynamics of Meropenem in Critically Ill Patients: How to Achieve Best Dosage Regimen According to the Clinical Situation.
    O'Jeanson A; Larcher R; Le Souder C; Djebli N; Khier S
    Eur J Drug Metab Pharmacokinet; 2021 Sep; 46(5):695-705. PubMed ID: 34403127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population Pharmacokinetics and Dosing Optimization of Gentamicin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.
    He S; Cheng Z; Xie F
    Drug Des Devel Ther; 2022; 16():13-22. PubMed ID: 35023902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.